Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX vs SP Adjuvant Chemotherapy in Gastric Cancer
NCT01679340Phase 2Unknown
- Sponsor
- Peking University
- Start
- Apr 2011
- Primary completion
- Mar 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin in gastric cancer (GC) and esophagogastric junction adenocarcinoma, sponsored by Peking University. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)esophagogastric junction adenocarcinoma
Beyond the preview
Go deeper on NCT01679340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679340.